Automotive, batteries: Covid-19, possible recession and low oil price — why they don’t matter for the EV revolution
According to Bloomberg, the electric vehicle revolution that by most
accounts was ramping up in 2020, faces one of the biggest threats since
EVs started to go mainstream in the last decade. The outbreak of the
novel Covid-19 (Coronavirus) in late December has paralysed key parts of
the Chinese economy.
By early March, the virus spread further across Europe and into the
US. On 9 March, oil prices crashed. With the markets rattled,
governments from Italy to the USA took increasingly drastic measures,
from locking down entire nations to banning travel and declaring states
of emergency. Although electrification is here to stay, these
developments are bad news for industries that were looking to tip the
scales in favour of electric this year.
Roskill View
While the recent oil price burst and the Covid-19 crisis could
suppress automotive sales worldwide, Roskill’s view on the long-term
demand for electric vehicles remains intact. Those countries adopting
stringent transport emissions regulations that ultimately push EV sales
are major oil importers: Europe, China, Japan, India, and South Korea. A
short-term bump in automotive sales and even long-term low prices won’t
change the view of these countries on oil dependency and the risk to
their economies and health systems.
Talking to Bloomberg,
Jose Lazuen, senior automotive practice analyst at Roskill, said
“Governments in China and in the European Union implemented measures to
accelerate the electrification of transport regardless of oil pricesâ€.
Concerns over pollution in large cities and its impact on citizens’
health have been more prominent, and oil price swings are unlikely to
change that. “Long-term, the vision of these governments is to diminish
exposure to oil markets as much as they can,†Lazuen said. “Whether that
will happen in the next 10 or 50 years, we don’t know.â€
Electric cars cost 50% to 70% more than conventional automobiles, but
prices are forecast to decline in the coming years as lithium-ion
battery technology evolves and manufacturers ramp up production. At the
current pace, Roskill estimates that the cost of electric vehicles will
start to match that of internal combustion engine cars beginning in
2023″.
Roskill’s NEW Lithium-ion Batteries: Outlook to 2029, 4th Edition
report is due to be published in April 2020 and provide detailed
analysis on supply, demand, trade, prices, cost curves and forecasts.
For more information or to subscribe, click here.
Posted by AGORACOM-JC
at 2:25 PM on Monday, March 23rd, 2020
SPONSOR: NORTHBUD (NBUD:CSE)
Sustainable low cost, high quality cannabinoid production and
procurement focusing on both bio-pharmaceutical development and
Cannabinoid Infused Products. The company recently received Canadian
Cultivation Licence for its Quebec Facility. Learn More.
Growing Preference For Edibles Over Smoking Cannabis Projected To Drive Global Cannabis Edibles Market Growth
Rising approval of recreational marijuana has surged the demand for legal cannabis
Thus, cannabis edibles are extensively approved in nations such as Canada, the US, Chile, Spain, Germany, Australia, and Israel
Cannabis edibles can be defined as food products that comprise cannabinoids and its spinoffs. Numerous cannabis edibles entail a considerable amount of cannabinoids that assist in decreasing anxiety and fatigue along with enhancing appetite. Also, cannabis edibles assist in improving relaxation & euphoria and are administered for recreational as well as medicinal reasons. The growing acceptance of cannabis is the key factor likely to drive the growth of the global cannabis edibles market during the forecast period.
Further, these products are deemed to be
effective, safe, and have intoxicating & healing impacts of
cannabis with no exposure to likely threats of cannabis smoking.
Consequently, this is projected to boost the expansion of the global
cannabis edibles market in the upcoming period. In addition, the rising
usage of cannabis edibles in beverages, baked items, chocolates,
candies, lozenges, and gummies are also anticipated to contribute to the
expansion of the global cannabis edibles market.
With the rising recognition of these products in the nations that are
making cannabis legal for medicinal purposes, the cannabis edibles
market is projected to register a substantial rate of growth during the
near future.
Apart from this, the rising approval of
recreational marijuana has surged the demand for legal cannabis. Thus,
cannabis edibles are extensively approved in nations such as Canada, the
US, Chile, Spain, Germany, Australia, and Israel. The cannabis industry
has surfaced in recent times as a productive business domain with a
huge prospect for market expansion and is driving the attention of
several new merchants and giant financiers. This is owing to the rising
social recognition of cannabis-infused edibles and recreational
marijuana products around the world.
Further, this has not only elevated the
revenues and sales of top firms but has also considerably contributed to
the revenue of numerous governments. Also, merchants are observing a
rise in the growth avenues in businesses entailing cannabis edibles like
ice creams, chocolates, and brownies, thereby fueling the global of the
global cannabis edibles market.
Nevertheless, several cannabis extracts
utilized in the making of the cannabis edibles are inclined to confront
judicial scrutiny and regulatory challenges in the coming period that
might obstruct the expansion of the global cannabis edibles market.
Nonetheless, the elevated usage of cannabis edibles to efficiently treat
several conditions such as epilepsy, cancer, chronic pain, anorexia,
arthritis, multiple sclerosis, Alzheimer’s, and nausea is anticipated to
cancel out the impacts of numerous market hindrances.
To cite, as announced on March 18, 2020, Clovr, a Kansas City-located
cannabis manufacturing firm, has collaborated with Wana Brands, a
cannabis edibles giant, to get edible products to the quickly
flourishing and much-awaited Missouri market. Introduced in 2010, the
Colorado brand already serves Oregon, Ohio, California, Illinois,
Michigan, Arizona, Oklahoma, and now Missouri, with intentions to
function in Florida and Maryland. Lately, Wana Brands also set up an
international footmark, getting its items to the Canadian cannabis
market via a licensing pact with Indiva Limited.
Source:
https://cannabisindustrynews24.com/1491/growing-preference-for-edibles-over-smoking-cannabis-projected-to-drive-global-cannabis-edibles-market-growth/
Tags: Cannabis, CBD, CSE, Hemp, Marijuana, stocks Posted in North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – Growing Preference For #Edibles Over Smoking #Cannabis Projected To Drive Global Cannabis Edibles Market Growth $CGC $ACB $APH $CRON.ca $OGI.ca
Posted by AGORACOM-JC
at 12:38 PM on Monday, March 23rd, 2020
SPONSOR: Datametrex AI Limited
(TSX-V: DM) A revenue generating small cap A.I. company that NATO and
Canadian Defence are using to fight fake news & social media
threats. The company announced three $1M contacts in Q3-2019. Click here for more info.
You can go to jail for spreading fake news about Covid-19
As the coronavirus (Covid-19) spreads, so does the misinformation
Recently referred to by the WHO as an “infodemic”, the volume of information that is both true and false has been communicated across all platforms globally
Geraint Crwys-Williams, chief business officer, Primedia Group and acting CEO, Primedia Broadcasting says, “Now, more than ever, the role of accountable and credible media has come to the fore. Government officials and healthcare professionals are using trusted broadcast media and digital platforms of established, verified, media outlets to circulate correct information on Covid-19. There has been a particular focus also on debunking the myths and misinformation in circulation, which is an important role of accountable media as a public service.â€
On Wednesday, the Minister for Cooperative Governance and Traditional Affairs, Dr Nkosazana Dlamini-Zuma, set out the Regulations in terms of Section 27 (2) of the Disaster Management Act. According to the Government Gazette, “Any person who publishes any statement, through any medium, including social media, with the intention to deceive any other person about— (a) Covid-19; (b) Covid-19 infection status of any person; or (c) any measure taken by the Government to address Covid-19, commits an offence and is liable on conviction to a fine or imprisonment for a period not exceeding six months, or both such fine and imprisonment.â€
Despite this, hoaxes are still being posted on social media, and are gaining traction. The most recent fake news post is a Facebook account purportedly belonging to President Cyril Ramaphosa that told South Africans to stay indoors at 10am as helicopters would be spraying chemicals across the country against coronavirus. 8,000 social media users spread that news onwards.
Adds Crwys-Williams, “We urge all South Africans to be mindful of the source of information that they receive. Misinformation does not just cause unnecessary panic; it also puts citizens at risk. We have a duty of care to our employees, our communities and our audience to provide accurate, informative communication to ensure we play our part in reducing, not just the spread of the virus, but of unnecessary panic too.â€
He adds that simply sharing misinformation could make someone complicit in the crime, even though this was not the intention.
“We recommend that South Africans go to their trusted news sources such as credible broadcast, print and online media for updates. The South African Government is being vigilant about ensuring that correct information is being disseminated across these channels. They also have a WhatsApp group on 060 012 3456 that offers up-to-date information – simply type ‘hi’ to be included.â€
Posted by AGORACOM
at 12:13 PM on Monday, March 23rd, 2020
Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTC:PEMTF) (the “Company” or “Mota”) is pleased to announce that since the launch of the Pure Herbal Immunity Blend under the First Class brand on March 14th, 2020, it has had an exceptional reception, acquiring 1,838 new customers.
The
all-natural Immunity Blend is made from 100% pure essential oils,
including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus,
rosemary, peppermint, spearmint and oregano. Due to customer demand for
pure and efficacious products to support the immune system, the Company
will be launching an Immune CBD oil, along with an Elderberry Gummy
product on Monday, March 23rd. The new Immune CBD product contains CBD,
B3, B12, Vitamin C and Zinc. Based on the success of the launch, First
Class will be increasing marketing efforts throughout the US.
The
Company plans to offer similar immune products in Europe through its
Sativida brand, which currently retails product in various jurisdictions
in Europe, including Spain, Portugal, Austria, Germany, France and the
United Kingdom.
The
Company anticipates the completion of the Sativida transaction in the
next seven days. Further to its January 10, 2020 news release, the
Company will acquire the intellectual property and trade names of
Sativida from VIDA BCN LABS SL (Spain) and Sativida OU (Estonia)
(collectively, “Sativida”).
The Company will license both back to Sativida in exchange for a
royalty associated with the gross revenues generated by Sativida.
“As
our customers around the globe face challenges in their daily lives, we
are working diligently to provide products to help families with
natural health needs. Our supply chain is operating uninterrupted and we
are quickly working to expand our immune support product line. We stand
ready to continue to adapt to market changes and innovate new products
to take advantage of the numerous opportunities ahead”, states Ryan
Hoggan, CEO of the Company.
About Mota Ventures Corp.
Mota
is seeking to become a vertically integrated global CBD brand. Its plan
is to cultivate and extract CBD into high-quality value-added products
from its Latin American operations and distribute it both domestically
and internationally. Its existing operations in Colombia consist of a
2.5-hectare site that has optimal year-round growing conditions and
access to all necessary infrastructure. Mota is looking to establish
sales channels and a distribution network internationally through the
acquisition of the Sativida and First Class CBD brands. Low cost
production, coupled with international, direct to customer sales
channels will provide the foundation for the success of Mota.
About Sativida
Sativida
is a producer and online retailer of CBD and branded CBD products in
various jurisdictions in Europe, including Spain and the United Kingdom.
Sativida currently develops and retails a vast range of organic CBD
oils and cosmetics across Europe and is currently expanding its
distribution network internationally. For more information on Sativida,
readers are encouraged to review their website, www.sativida.es.
ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP. Ryan Hoggan Chief Executive Officer
For
further information, readers are encouraged to contact the President of
the Company, Joel Shacker, at +604.423.4733 or by email at [email protected]or www.motaventuresco.com
Posted by AGORACOM-JC
at 4:12 PM on Thursday, March 19th, 2020
With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB)
has a database that almost every medical cannabis and CBD company would
kill for. Patient visits increased 351% in Q4 and 800% in February.
But would Coronavirus social gathering imitations put the clinic network
at risk?
No. In fact, it has had the opposite effect, with the clinics being designated an essential service. Moreover, Empower has had to actually increase operating hours.
Watch this interview with the Company’s CEO, Steven McAuley, who is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which also explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history. Â
Grab your favourite beverage and settle in to watch what may be your next great small cap investment.
Posted by AGORACOM-JC
at 3:00 PM on Thursday, March 19th, 2020
SPONSOR: Datametrex AI Limited
(TSX-V: DM) A revenue generating small cap A.I. company that NATO and
Canadian Defence are using to fight fake news & social media
threats. The company announced three $1M contacts in Q3-2019. Click here for more info.
How Coronavirus is Impacting Cyberspace
Hackers were also strategizing to spread fake news to create further confusion
By investigating the dark web marketplace, CYFIRMA uncovered illicit groups selling organic medicine claiming to cure and eradicate the COVID-19 virus
These discussions in the hackers’ communities were carried out in Mandarin, Japanese and English
These are interesting times – the world is witnessing an
unprecedented onslaught of upheavals not just in the ‘real-world’ but
also in the cyber world. We greeted 2020 gingerly knowing the trade war
between the U.S. and China was going to bring about economic uncertainty
but little did we know a global pandemic was upon us, with the
Coronavirus having an impact even on cyberspace.
By CYFIRMA RESEARCH
While healthcare workers are battling the COVID-19 virus, countries are in lockdown mode, and the global economy hangs in the balance, another war is raging in cyberspace.
Cyber risks and threats have multiplied with many more attack
vectors, and hackers’ techniques evolving faster than ever, blending
technical prowess with sophisticated social engineering. The current
challenge with the virus pandemic is a test of nations’ and businesses’
preparedness and resiliency on all fronts.
CYFIRMA’s threat visibility and intelligence research
revealed a massive increase of over 600% of cyberthreat indicators
related to the Coronavirus pandemic from February to early March.
Threat indicators are made up of conversations observed and uncovered
in the dark web, hackers’ forums, and closed communities. What our
researchers have seen and heard in these communities do not bode well
for governments and businesses – hackers are hard at work, actively
planning how to leverage this climate of fear and uncertainty to attain
their political and financial objectives.
The United States Computer Emergency Readiness Team (US-CERT) has
sent out alerts on scams tricking people into revealing personal
information or donating to fraudulent charities, all under the pretext
of helping to contain and manage the coronavirus. The Federal Trade
Commission has also warned about similar scams.
CYFIRMA’s research team and
multiple security vendors have reported that threat actors have used
fear tactics to spread malware, including LokiBot, RemcosRAT, TrickBot,
and FormBook.
These hackers’ communities span far and wide, communicating in
Cantonese, Mandarin, Russian, English, and Korean, unleashing campaigns
one after another to wreak havoc on unsuspecting nations and
enterprises.
On Dark Web
forums, a group from Hong Kong hatched a plan to create a new phishing
campaign targeting the population from mainland China. The group aimed
to create distrust and incite social unrest by assigning blame to the
Chinese Communist Party.
A deeper analysis of hackers’ conversations also revealed groups from
Taiwan discussing similar phishing and spam campaigns, specifically
targeting influential persons in mainland China to cause further unrest.
Korean-speaking hackers were planning to make financial gains using
sophisticated phishing campaigns, loaded with sensitive data
exfiltration malware and creating a new variant of EMOTET virus (EMOTET
is a malware strain that was first detected in 2014 and is one of the
most prevalent threats in 2019). These hackers were planning to target
Japan, Australia, Singapore, and the U.S.
CYFIRMA’s researchers also observed North Korean hackers targeting
South Korean businesses. The phishing email had the Korean language
title “Coronavirus Correspondenceâ€, tricking recipients into opening
them and launching malware into machines and networks.
With COVID-19, many hacker groups were observed to be using brand
impersonation with fake emails claiming to represent authoritative
bodies such as the Centers for Disease Control (CDC) and the World
Health Organization (WHO). The subject line and content of these emails
were very enticing, offering news updates and cures to the ailment.
We also noticed coronavirus-themed emails designed to look like
emails from the organizations’ leadership team and sent to all
employees.
Embedded with malware that would infect corporate networks, these
phishing attacks deploy social engineering tactics to steal data and
assets.
Other than unleashing cyberattacks to steal data, we also witnessed
the planning of fake websites to sell face masks and other health
apparatus using bitcoin in China, Japan, and the US.
To aggravate matters, hackers were also strategizing to spread fake
news to create further confusion. By investigating the dark web
marketplace, CYFIRMA uncovered illicit groups selling organic medicine
claiming to cure and eradicate the COVID-19 virus. These discussions in
the hackers’ communities were carried out in Mandarin, Japanese and
English.
A
new malware called ‘CoronaVP’ was being discussed by a Russian hacking
community; this could lead to a new ransomware or EMOTET strain,
designed to steal personal information.
Hackers leveraging on the COVID-19 pandemic are motivated by a
combination of personal financial gain as well as political espionage to
cause social upheavals. Threat actors in the world of cybercrimes are
well-equipped with tools, technology, expertise and financing to further
both commercial and political agendas. In our hyper-connected digital
world, cyber-crime is a lucrative business, and we should expect attacks
to be more frequent and more sophisticated as the pandemic continues to
cast a shadow over the global economy.
What we have witnessed in the field of cyber-intelligence has taught
us the importance of staying vigilant, and frequently, the most
dangerous forces at work are those we cannot see.
The importance of relevant and timely threat intelligence cannot be
over-emphasized as early detection of cyber threats could save
organizations from hefty financial penalties and irreversible brand
damage.
Posted by AGORACOM
at 12:51 PM on Thursday, March 19th, 2020
RECENT HIGHLIGHTS
First Class CBD brand achieved sales of Cdn$2,981,000 February 2020
Marketing efforts improved gross margins by 4.9% from January 2020 to February 2020.
February 2020 represents an increase of 832% over the same period last year.
Plans to continue growth of First Class in the United States over the balance of 2020, as well as an expansion into the European market.
Formalized Joint Venture With Bevcanna Enterprises: Read More
Will share equal ownership in the Joint Venture and will be jointly responsible for developing and funding its operations
Company will provide manufacturing, marketing and distribution infrastructure in the European market.
Parties have determined an initial product launch and will provide further details on specific regions and timing once finalize
Announced Collaboration for Sativida US Expansion Read More
Unified Funding will provide assistance to Sativida with product
sourcing, packaging, shipping, payment infrastructure and marketing
Sativida has become the number one search-ranked online retailer of CBD products in Spain and Mexico
Entered into Licensing Agreement with Phenome One Read More
A privately held full-service live genetic and seed preservation cannabis company.
Mota will have full access to Canada’s largest live genetic cannabis library with over 350 cultivars
Mota will have the right to propagate, cultivate, harvest and process a minimum of 10 selected cultivars
2 World Class Brands:
#1. FIRST CLASS CBD: ONE OF THE LARGEST US BASED ONLINE RETAILERS OF CBD PRODUCTS
HIGHLIGHTS:
Leader in online CBD sales in North America
Crop to package model: US grown CBD hemp
Acquired at a 1.5 times revenue valuation
Current customer base 142,000 customers -with additional leads of over 424,000 potential new customers
2019 Sales of $19.2M USD/ EBITDA of 2.7M USD
 #2. SATIVIDA: ONLINE DIRECT TO CONSUMER RETAILER OF A VAST RANGE OF ORGANICE CBD OILS AND COSMETICS
HIGHLIGHTS:
Current distributor of CBD products in Spain, Portugal, Austria, Germany, France and the United Kingdom
Number one search-ranked online retailer in Spain and Mexico
Award winning product line known for its minimal heavy metal content and accurate CBD levels
100% organic products
About Mota Ventures Corp.
Mota Ventures is seeking to
become a vertically integrated global CBD brand. Its plan is to
cultivate and extract CBD into high-quality value added products from
its Latin American operations and distribute it both domestically and
internationally. Mota has established distribution networks through the
acquisition of First Class CBD in the United States and Sativida in
Europe. Mota Ventures is also seeking to acquire revenue producing CBD
brands and operations in both Europe and North America, with the goal of
establishing an international distribution network for CBD products.
Low cost production, coupled with international, direct to customer,
sales channels will provide the foundation for the success of Mota
Ventures.
Posted by AGORACOM-JC
at 7:24 AM on Thursday, March 19th, 2020
Empower Clinics adapts operational processes to manage continued record patient counts during COVID-19 outbreak
Patient visits in corporate clinics continue at record pace, with patients demonstrating an even greater need for plant-based medicine, as the impact of COVID-19 becomes more pervasive
State’s of Arizona and Oregon have declared a State of Emergency over the novel coronavirus outbreak therefore, as a medical service provider, Empowers corporate medical clinics are considered an essential service and are not subject to certain mandated closures
VANCOUVER, BC / March 18, 2020 / EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented life sciences company, announces that patient visits in corporate clinics continue at record pace, with patients demonstrating an even greater need for plant-based medicine, as the impact of COVID-19 becomes more pervasive.
“The coronavirus crisis is impacting all aspects of our lives, but
our clinics remain incredibly busy, as patients show how important their
medical cannabis treatment options are to manage increased levels of
anxiety, stress, chronic pain and PTSD” said Steven McAuley, Chairman
& CEO of Empower. “We had to quickly adapt clinic operating
procedures to ensure optimum safety for employees and patients, updated
cleaning and sanitation protocols, and provided extensive new
communications to our team and patients.”
The State’s of Arizona and Oregon have declared a State of Emergency
over the novel coronavirus outbreak therefore, as a medical service
provider, Empowers corporate medical clinics are considered an essential
service and are not subject to certain mandated closures.
The Company has made changes to clinic operations and patient
management based on the most recent recommendations from the (CDC)
Centers for Disease Control and Prevention, and their guidance for
healthcare facilities.
Empower is a vertically-integrated health & wellness brand with
it’s first hemp-derived CBD extraction facility under development, the
Company produces its proprietary line of cannabidiol (CBD) based
products and distributes products through company owned and franchised
clinics, with wholesale partnerships, online channels and with new
retail opportunities nationwide in the U.S. The company is a leading
multi-state operator of a network of physician-staffed wellness clinics,
focused on helping patients improve and protect their health, through
innovative physician recommended treatment options. The company has
commenced activity on how to connect its significant data, to the
potential of the efficacy of alternative treatment options related to
hemp-derived cannabidiol (CBD) therapies.
For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements”
or “forward-looking information” (collectively “forward looking
statements”) within the meaning of applicable Canadian securities laws.
All statements, other than statements of historical fact, are
forward-looking statements and are based on expectations, estimates and
projections as at the date of this news release.Forward-looking statements
can frequently be identified by words such as “plans”, “continues”,
“expects”, “projects”, “intends”, “believes”, “anticipates”,
“estimates”, “may”, “will”, “potential”, “proposed” and other similar
words, or information that certain events or conditions “may” or “will”
occur. Forward-looking statements in this news release include
statements regarding; the Company’s intention to open a hemp-based CBD
extraction facility, the expected benefits to the Company and its
shareholders as a result of the proposed acquisitions and partnerships;
the effectiveness of the extraction technology; the expected benefits
for Empower’s patient base and customers; the benefits of CBD based
products; the effect of the approval of the Farm Bill; the growth of the
Company’s patient list and that the Company will be positioned to be a
market-leading service provider for complex patient requirements in 2019
and beyond. Such statements are only projections, are based on
assumptions known to management at this time, and are subject to risks
and uncertainties that may cause actual results, performance or
developments to differ materially from those contained in the
forward-looking statements, including; that the Company may not open a
hemp-based CBD extraction facility; that legislative changes may have an
adverse effect on the Company’s business and product development; that
the Company may not be able to obtain adequate financing to pursue its
business plan; general business, economic, competitive, political and
social uncertainties; failure to obtain any necessary approvals in
connection with the proposed acquisitions and partnerships; and other
factors beyond the Company’s control. No assurance can be given that any
of the events anticipated by the forward-looking statements will occur
or, if they do occur, what benefits the Company will obtain from them.
Readers are cautioned not to place undue reliance on the forward-looking
statements in this release, which are qualified in their entirety by
these cautionary statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or revise any
forward-looking statements in this release, whether as a result of new
information, future events or otherwise, except as expressly required by
applicable laws.
Tags: CSE, Hemp, Marijuana, small cap Posted in Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Daily Patient Count Continues at Record Pace with Medical Cannabis Certifications Deemed an Essential Service $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca
Posted by AGORACOM-JC
at 5:23 PM on Wednesday, March 18th, 2020
First Class CBD has launched a new “immune support” product that has generated significant demand since it was released
This is the first of a number of new CBD products aimed at promoting personal immune health that First Class is developing
During the first four days, company acquired over 1,000 customers and will be scaling rapidly
VANCOUVER, BC / March 18, 2020 /Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ1)(OTC:PEMTF) (the “Company“) announces that First Class CBD has launched a new “immune support” product that has generated significant demand since it was released. This is the first of a number of new CBD products aimed at promoting personal immune health that First Class is developing.
One of our primary competitive advantages as a business is our
ability to adapt to market changes. With the immense demand in the
market for products to promote personal immune system health, we
launched a First Class immune product; during the first four days, we
acquired over 1,000 customers and will be scaling rapidly. Next week we
will be launching a complete line of immunity products, including a CBD
oil plus B-vitamins, Vitamin C and Zinc.
Our mission is to provide pure and efficacious products to our
customers that depend upon us throughout the United States and Europe.
Our supply chain is functioning uninterrupted. The Company has
personally met with suppliers in the United States and are confident in
its ability to continue to meet the demands of the current sales volume,
and new product lines for March 2020 and beyond.
“I am extremely pleased with the success of our launch of our new
product line. Our ability to adapt and innovate is stronger than ever.
Demand for our new immune category has been exceptional and I believe
this will be a significant driver to revenue in 2020,” stated Ryan
Hoggan, CEO of the Company.
About Mota Ventures Corp.
Mota is seeking to become a vertically integrated global CBD brand.
Its plan is to cultivate and extract CBD into high-quality value-added
products from its Latin American operations and distribute it both
domestically and internationally. Its existing operations in Colombia
consist of a 2.5-hectare site that has optimal year-round growing
conditions and access to all necessary infrastructure. Mota is looking
to establish sales channels and a distribution network internationally
through the acquisition of the Sativida and First Class CBD brands. Low
cost production, coupled with international, direct to customer sales
channels will provide the foundation for the success of Mota.
ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP. Ryan Hoggan Chief Executive Officer
For further information, readers are encouraged to contact the
President of the Company, Joel Shacker, at +604.423.4733 or by email at [email protected] or www.motaventuresco.com
Neither the Canadian Securities Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the Canadian
Securities Exchange) accepts responsibility for the adequacy or accuracy
of this press release, which has been prepared by management.
All statements in this press release, other than statements of
historical fact, are “forward-looking information” with respect to the
Company within the meaning of applicable securities laws, including with
respect to the business prospects of First Class CBD and its new
product lines, its plans to become a vertically integrated global CBD
brand, its plans to cultivate and extract cannabis to produce CBD and
high-quality value added CBD products in Latin America for distribution
domestically and internationally. The Company provides forward-looking
statements for the purpose of conveying information about current
expectations and plans relating to the future and readers are cautioned
that such statements may not be appropriate for other purposes. By its
nature, this information is subject to inherent risks and uncertainties
that may be general or specific and which give rise to the possibility
that expectations, forecasts, predictions, projections or conclusions
will not prove to be accurate, that assumptions may not be correct and
that objectives, strategic goals and priorities will not be achieved.
These risks and uncertainties include but are not limited those
identified and reported in the Company’s public filings under the
Company’s SEDAR profile at www.sedar.com.
Although the Company has attempted to identify important factors that
could cause actual actions, events or results to differ materially from
those described in forward-looking information, there may be other
factors that cause actions, events or results not to be as anticipated,
estimated or intended. There can be no assurance that such information
will prove to be accurate as actual results and future events could
differ materially from those anticipated in such statements. The Company
disclaims any intention or obligation to update or revise any
forward-looking information, whether as a result of new information,
future events or otherwise unless required by law.
Posted by AGORACOM-JC
at 3:46 PM on Wednesday, March 18th, 2020
SPONSOR: Tartisan Nickel (TN:CSE)
Kenbridge Property has a measured and indicated resource of 7.14
million tonnes at 0.62% nickel, 0.33% copper. Tartisan also has
interests in Peru, including a 20 percent equity stake in Eloro
Resources and 2 percent NSR in their La Victoria property. Click her for more information
—————————-
Volkswagen to start using high-nickel EV batteries
Volkswagen is aiming to produce 3 million electric cars by 2025.
Company is also embarking on producing EV battery as well.
Reuters
FRANKFURT: Volkswagen will raise the amount of nickel
used in it electric car battery cells to 80% in the next year from 65%
at present, Frank Blome, head of battery cells at the carmaker said on
Tuesday.
Volkswagen’s current electric car battery cell contains 65% nickel, 15% cobalt and 20% manganese. Next generation batteries will have 80% nickel, 10% cobalt and 10% manganese, Blome told analysts on a call.
Volkswagen
is embarking on a mass production push to build 3 million electric cars
by 2025, requiring 300 gigawatt hours worth of battery cells, mainly in
Asia and Europe, he said.
Ramping up manufacturing battery packs
at scale will help the carmaker to cut battery cell costs far below
$100 per kilowatt hour by 2025, he said.
